366 related articles for article (PubMed ID: 30845980)
1. Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord.
Thaweesapphithak S; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Roytrakul S; Manochantr S
Stem Cell Res Ther; 2019 Mar; 10(1):79. PubMed ID: 30845980
[TBL] [Abstract][Full Text] [Related]
2. The Biological Characteristics of Placenta Derived Mesenchymal Stem Cells Cultured in Human Serum.
Thaweesapphithak S; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Manochantr S
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S75-83. PubMed ID: 29917345
[TBL] [Abstract][Full Text] [Related]
3. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells].
Yang T; Chen GH; Xue SL; Qiao M; Liu HW; Tian H; Qiao SM; Chen F; Chen ZZ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):715-9. PubMed ID: 23336223
[TBL] [Abstract][Full Text] [Related]
5. Effect of serum choice on replicative senescence in mesenchymal stromal cells.
Liu Y; Li YQ; Wang HY; Li YJ; Liu GY; Xu X; Wu XB; Jing YG; Yao Y; Wu CT; Jin JD
Cytotherapy; 2015 Jul; 17(7):874-84. PubMed ID: 25800776
[TBL] [Abstract][Full Text] [Related]
6. Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications.
Tesarova L; Jaresova K; Simara P; Koutna I
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731615
[TBL] [Abstract][Full Text] [Related]
7. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
[TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.
Rallapalli S; Guhathakurta S; Bishi DK; Subbarayan R; Mathapati S; Korrapati PS
Biotechnol Lett; 2021 Oct; 43(10):2067-2083. PubMed ID: 34499291
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition.
Ma J; Wu J; Han L; Jiang X; Yan L; Hao J; Wang H
Stem Cell Res Ther; 2019 Jan; 10(1):19. PubMed ID: 30635045
[TBL] [Abstract][Full Text] [Related]
10. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
[TBL] [Abstract][Full Text] [Related]
11. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
12. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord serum as an alternative to fetal bovine serum for in vitro expansion of umbilical cord mesenchymal stromal cells.
Afzal E; Pakzad M; Nouri M; Moghadasali R; Zarrabi M
Cell Tissue Bank; 2023 Mar; 24(1):59-66. PubMed ID: 35635634
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important.
Kong CM; Lin HD; Biswas A; Bongso A; Fong CY
Cytotherapy; 2019 Apr; 21(4):483-495. PubMed ID: 30879965
[TBL] [Abstract][Full Text] [Related]
15. Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge.
Boland LK; Burand AJ; Boyt DT; Dobroski H; Di L; Liszewski JN; Schrodt MV; Frazer MK; Santillan DA; Ankrum JA
Front Immunol; 2019; 10():1080. PubMed ID: 31134100
[TBL] [Abstract][Full Text] [Related]
16. Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells.
Jabbarpour Z; Aghayan S; Arjmand B; Fallahzadeh K; Alavi-Moghadam S; Larijani B; Aghayan HR
Stem Cell Res Ther; 2022 Jun; 13(1):268. PubMed ID: 35729640
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
[TBL] [Abstract][Full Text] [Related]
18. Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum.
Wang L; Yang Y; Zhu Y; Ma X; Liu T; Zhang G; Fan H; Ma L; Jin Y; Yan X; Wei J; Li Y
Mol Med Rep; 2012 Oct; 6(4):760-6. PubMed ID: 22824952
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta.
Beeravolu N; McKee C; Alamri A; Mikhael S; Brown C; Perez-Cruet M; Chaudhry GR
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28447991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
